GSA for Human: HRA001175 Information

• Accession: HRA001175
• Title: HRA001175 Information
• Description: HRA001175 Rolling-translated EGFR Variants Sustain EGFR Signaling and Promote Glioblastoma Tumorigenicity
• Basic Information: HRA001175 Rolling-translated EGFR Variants Sustain EGFR Signaling and Promote Glioblastoma Tumorigenicity

---

GSA for Human: HRA001176 Information

• Accession: HRA001176
• Title: HRA001176 Information
• Description: HRA001176 Rolling-translated EGFR Variants Sustain EGFR Signaling and Promote Glioblastoma Tumorigenicity (total RNA data)
• Basic Information: HRA001176 Rolling-translated EGFR Variants Sustain EGFR Signaling and Promote Glioblastoma Tumorigenicity (total RNA data)

---

GSA for Human: HRA001603 Information

• Accession: HRA001603
• Title: HRA001603 Information
• Description: HRA001603 PHLDB2 mediates cetuximab resistance via interacting with EGFR in latent metastasis of colorectal cancer
• Basic Information: HRA001603 PHLDB2 mediates cetuximab resistance via interacting with EGFR in latent metastasis of colorectal cancer

---

GSA for Human: HRA000725 Information

• Accession: HRA000725
• Title: HRA000725 Information
• Description: HRA000725 Study on plasma ctDNA dynamic gene changes in patients with EGFR mutation in non-small cell lung cancer
• Basic Information: HRA000725 Study on plasma ctDNA dynamic gene changes in patients with EGFR mutation in non-small cell lung cancer

---

GSA for Human: HRA001818 Information

• Accession: HRA001818
• Title: HRA001818 Information
• Description: HRA001818 epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
• Basic Information: HRA001818 epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer

---

GSA for Human: HRA001884 Information

• Accession: HRA001884
• Title: HRA001884 Information
• Description: HRA001884 Longitudinal circulating tumor DNA (ctDNA) profiling in metastatic colorectal cancer patients during anti-EGFR therapy
• Basic Information: HRA001884 Longitudinal circulating tumor DNA (ctDNA) profiling in metastatic colorectal cancer patients during anti-EGFR therapy

---

GSA for Human: HRA002387 Information

• Accession: HRA002387
• Title: HRA002387 Information
• Description: HRA002387 A case of lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
• Basic Information: HRA002387 A case of lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib

---

GSA for Human: HRA001462 Information

• Accession: HRA001462
• Title: HRA001462 Information
• Description: HRA001462 Genomic signatures define three subtypes of resected EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes
• Basic Information: HRA001462 Genomic signatures define three subtypes of resected EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes

---